MIT-Covid-Vaccine-01-press_0
A new protein subunit vaccine developed at MIT and Beth Israel Deaconess Medical Center may offer an inexpensive, easy-to-store, and effective alternative to RNA vaccines for Covid-19. Pictured is a schematic of the vaccine.

Researchers at MIT and Beth Israel Deaconess Medical Center are exploring a yeast-based alternative to RNA vaccines.

A new paper highlights a vaccine, which comprises fragments of the SARS-CoV-2 spike protein arrayed on a virus-like particle, that reportedly elicited a strong immune response and protected animals against viral challenge, according to a post on MIT’s website.

Get the full story at our sister site, Pharmaceutical Processing World.